BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Lone Star Bio

  Vermillion Announces the Grant of Two Ovarian Cancer Diagnostic Patents

  Vermillion announced today that it has been granted two new US patents that significantly expand coverage for its core technologies, OVA1 and Overa.

  February 5, 2018

   · 

  1 min read
• Business

  JDRF and Cam Med Partner to Develop Flexible Patch Pump for Automated Insulin Delivery Systems

  This funding commitment from JDRF will enable Cam Med to further the development of its innovative Evopump, an ultra-thin and flexible, bandage-like patch pump.

  February 5, 2018

   · 

  3 min read
• Teewinot Life Sciences Corporation’s Subsidiary, Teewinot Technologies, Ltd., Announced Today: Grant of a New Patent With Broad Claims to Biosynthetic Production of Cannabinoids

  The claims of the ‘292 patent cover biosynthetic production of cannabinoids and cannabinoid analogs.

  February 5, 2018

   · 

  2 min read
• Pharm Country

  Life Sciences Greenhouse of Central PA and Ben Franklin Technology Partners of Central & Northern PA Invest $500,000 in Ocunova Inc.

  This investment will aid in the development and clinical trials of a first-in-class drug candidate for the treatment of diabetic dry eye patients.

  February 5, 2018

   · 

  2 min read
• Genetown

  Blue Earth Diagnostics Announces Presentation at Upcoming ASCO 2018 Genitourinary Cancers Symposium on Fluciclovine (18F) PET/CT Impact on Clinical Management of Recurrent Prostate Cancer

  Blue Earth Diagnostics announced the upcoming presentation of initial results from the FALCON clinical trial (NCT02578940) of fluciclovine (18F) PET/CT, evaluating its impact on patient management in biochemically recurrent prostate cancer patients scheduled for salvage treatment with curative intent.

  February 5, 2018

   · 

  5 min read
• Biotech Beach

  EBD Group: BIO-Europe Spring(R) Returns to Amsterdam for High-Level Partnering Among Innovative Biotech, Pharma and Investors

  The twelfth annual BIO-Europe Spring(R) international partnering conference returns to Amsterdam, The Netherlands, March 12-14, 2018 at the Amsterdam RAI Convention Center.

  February 5, 2018

   · 

  3 min read
• 

  Lone Star Bio

  Seisa Medical Closes $42.5MM Recapitalization and Acquisition Line

  The cash will be used to pay fees and expenses associated with the transaction, fund a dividend to shareholders and complete acquisitions.

  February 5, 2018

   · 

  2 min read
• Invictus Receives $16.5M From Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018 to 27,200 Kg

  Invictus Medical is pleased to announce that it has received an additional $16,536,234 from the exercise of previously issued warrants and options since December 22, 2017, bringing Invictus’ cash balance to approximately $38M.

  February 5, 2018

   · 

  10 min read
• Drug Development

  CytRx Highlights Second NantCell Clinical Trial Evaluating Immuno-Oncology Agents and Cell-based Therapies in Combination with Aldoxorubicin in Patients With Advanced Squamous Cell Carcinoma

  The first trial in pancreatic cancer patients commenced in January 2018.

  February 5, 2018

   · 

  3 min read
• Health AI Startup Medial EarlySign Predicts Which Diabetic Patients Will Suffer Kidney Damage Within One Year

  This represents 25% more patients than would have been identified by commonly used clinical tools and judgement.

  February 5, 2018

   · 

  4 min read